
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors

When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors
Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how clinical research site management is changing – and marching towards
R’Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss how decentralized clinical trials (DCTs) can expand access to

We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North American Operations at SCOPE International, an independent full-service CRO serving

When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team expects quality and performance in return for their investment. CROs
Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced

Most, if not all, industry events have gone virtual in 2020. Clinical Innovations Summit is the most recent one to convert to an online setting,

Women of Color in Pharma (WOCIP) has emerged as a leading organization teaching our industry how to empower women of color through bold action. Their

Making it through the clinical trial start-up process is critical for any study – and takes a lot of effort under normal circumstances. But today,

6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.

If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.

Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?

Getting new treatments approved has never been harder, but recent research reveals that the regulatory agency has also never been faster. So why is it
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
Get new original content and a hand-curated selection of the best life science articles from around the web directly in your inbox. Subscribe to The ArcheMedX Clinical Research Newsletter
See how ArcheMedX applies behavioral science to transform learning and generate actionable insights